Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5.2Revenue (TTM) $M0.6Net Margin (%)-4,157.8Altman Z-Score-31.1
Enterprise Value $M7.9EPS (TTM) $-3.0Operating Margin %-4,948.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score0.0Pre-tax Margin (%)-4,157.8Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-52.0Quick Ratio1.2Cash flow > EarningsN
Price/Sales2.75-y EBITDA Growth Rate %-29.5Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-181.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-1,461.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M27.3ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ETRM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ETRMBill Gates 2009-06-30 Sold Out $112.5 - $365.4
($216.49)
$ 0.19-100%Sold Out0
ETRMBill Gates 2009-03-31 Buy $99 - $224.1
($134.21)
$ 0.19-100%New holding663
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ETRM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ETRM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DeLange Peter M.SVP, Ops & Bus Dev 2016-06-03Buy20,000$0.55-65.45view
GLADNEY DAN WCEO 2015-11-12Buy50,000$2.7-92.96view
KNUDSON MARK BChrmn, Pres & CEO 2015-11-12Buy20,667$2.4-92.08view
KNUDSON MARK BChrmn, Pres & CEO 2015-08-13Buy20,200$3.75-94.93view
GLADNEY DAN WCEO 2015-05-16Buy5,650$10.8-98.24view
FRIEDMAN CATHYDirector 2014-06-19Buy787$25.5-99.25view
EVNIN LUKEDirector 2014-01-08Sell37,106$37.5-99.49view
EVNIN LUKEDirector 2014-01-08Sell37,106$37.5-99.49view
Jansz Anthony P.Director 2013-02-27Buy10,000$14.25-98.67view
WHITEBOX ADVISORS LLC 2012-06-27Sell3,167$48.3-99.61view

Quarterly/Annual Reports about ETRM:

News about ETRM:

Articles On GuruFocus.com
Kevin Douglas Bets on EnteroMedics; Popeyes and AMERCO Top Estimates May 28 2015 
Canaccord Genuity Remains Bullish on EnteroMedics Following Q4 Earnings Feb 19 2015 
Analysts Are Bullish On EnteroMedics Following FDA Approval Of Obesity Treatment Jan 16 2015 
EnteroMedics Inc. Reports Operating Results (10-K) Mar 07 2011 
EnteroMedics Inc. Reports Operating Results (10-Q) Nov 08 2010 
EnteroMedics Inc. Reports Operating Results (10-Q) Aug 06 2010 
EnteroMedics Inc. Reports Operating Results (10-Q) May 07 2010 
EnteroMedics Inc. Reports Operating Results (10-Q) Nov 16 2009 
EnteroMedics Inc. Reports Operating Results (10-Q) Aug 07 2009 
EnteroMedics Inc. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
ENTEROMEDICS INC Financials Aug 20 2016
ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events,... Aug 17 2016
EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors Aug 17 2016
EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors Aug 17 2016
EnteroMedics Announces Publication of 24 Month ReCharge Clinical Study Data in Obesity Surgery Aug 15 2016
EnteroMedics Announces Publication of 24 Month ReCharge Clinical Study Data in Obesity Surgery Aug 15 2016
ENTEROMEDICS INC Files SEC form 10-Q, Quarterly Report Aug 12 2016
EnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 Aug 11 2016
EnteroMedics reports 2Q loss Aug 04 2016
ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 04 2016
EnteroMedics Reports Second Quarter 2016 Financial Results Aug 04 2016
EnteroMedics Reports Second Quarter 2016 Financial Results Aug 04 2016
Pharma and tech converge in "fantastic voyage" to fight disease Aug 01 2016
Pharma and tech converge in 'fantastic voyage' to fight disease Aug 01 2016
GSK and Google parent forge $715 mln bioelectronic medicines firm Aug 01 2016
ENTEROMEDICS INC Files SEC form 8-K, Other Events Jul 20 2016
ENTEROMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jul 15 2016
Cheap Stocks: These Aren't Necessarily a Lucky 7 Jul 13 2016
ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 06 2016
EnteroMedics Highlights Recent Patient Success with vBloc® Therapy in Combination with vBloc®... Jun 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)